Helen Sabzevari insider trades: Precigen (PGEN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Helen reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | PGEN | ↓ Sell | 346,836 | $5.89 | $2.0M | Direct | Jul 1, 2026 (2d) |
| Aug 25, 2023 | PGEN | ↓ Sell | 76,969 | $1.53 | $118K | Direct | Aug 25, 2023 (0d) |
| Aug 18, 2023 | PGEN | ↓ Sell | 55,855 | $1.66 | $93K | Direct | Aug 18, 2023 (0d) |
| Aug 11, 2023 | PGEN | ↓ Sell | 41,436 | $1.44 | $60K | Direct | Aug 11, 2023 (0d) |
| Aug 4, 2023 | PGEN | ↓ Sell | 52,870 | $1.10 | $58K | Direct | Aug 4, 2023 (0d) |
| Jan 27, 2023 | PGEN | ↑ Buy | 22,857 | $1.75 | $40K | Direct | Jan 30, 2023 (3d) |
| May 13, 2022 | PGEN | ↓ Sell | 177,968 | $1.19 | $211K | Direct | May 16, 2022 (3d) |
| Jan 5, 2022 | PGEN | ↓ Sell | 6,960 | $3.59 | $25K | Direct | Jan 6, 2022 (1d) |
| Jan 3, 2022 | PGEN | ↓ Sell | 3,848 | $3.67 | $14K | Direct | Jan 4, 2022 (1d) |
| Jul 19, 2021 | PGEN | ↓ Sell | 12,531 | $5.43 | $68K | Direct | Jul 20, 2021 (1d) |
| May 13, 2021 | PGEN | ↓ Sell | 47,433 | $6.40 | $304K | Direct | May 14, 2021 (1d) |
| Jan 6, 2021 | PGEN | ↓ Sell | 260,045 | $8.92 | $2.3M | Direct | Jan 7, 2021 (1d) |
| Jan 5, 2021 | PGEN | ↓ Sell | 9,040 | $10.56 | $96K | Direct | Jan 6, 2021 (1d) |
| Jan 4, 2021 | PGEN | ↓ Sell | 5,279 | $10.16 | $54K | Direct | Jan 5, 2021 (1d) |
| Jul 20, 2020 | PGEN | ↓ Sell | 12,220 | $4.58 | $56K | Direct | Jul 21, 2020 (1d) |
| May 15, 2020 | PGEN | ↓ Sell | 217,527 | $2.37 | $516K | Direct | May 18, 2020 (3d) |
| Apr 1, 2020 | PGEN | ↓ Sell | 5,450 | $3.01 | $16K | Direct | Apr 2, 2020 (1d) |
| Jan 6, 2020 | XON | ↓ Sell | 6,732 | $5.83 | $39K | Direct | Jan 7, 2020 (1d) |
| Jan 3, 2020 | XON | ↓ Sell | 3,886 | $5.77 | $22K | Direct | Jan 6, 2020 (3d) |
| Jan 2, 2020 | XON | ↓ Sell | 4,830 | $5.60 | $27K | Direct | Jan 3, 2020 (1d) |
| Oct 1, 2019 | XON | ↓ Sell | 5,005 | $5.50 | $28K | Direct | Oct 2, 2019 (1d) |
| Jul 18, 2019 | XON | ↓ Sell | 8,484 | $7.47 | $63K | Direct | Jul 19, 2019 (1d) |
| Jul 1, 2019 | XON | ↓ Sell | 4,822 | $7.76 | $37K | Direct | Jul 2, 2019 (1d) |
| Jan 3, 2019 | XON | ↓ Sell | 3,832 | $7.07 | $27K | Direct | Jan 4, 2019 (1d) |
| Jul 18, 2018 | XON | ↓ Sell | 8,402 | $14.54 | $122K | Direct | Jul 19, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PGEN insiders
Open-market trades in the last 12 months
About Helen Sabzevari's insider trades
Helen Sabzevari is President and CEO at Precigen (PGEN). Since Jul 18, 2018, Helen has reported 1 open-market purchase worth $40K and 24 sales worth $6.4M on SEC Form 4. In the last 12 months: 1 sale ($2.0M).
Their filings also include option exercises (31 filings), grants and awards (24 filings), shares withheld for taxes (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.